Day: August 24, 2021

RIO DE JANEIRO, Brazil, Aug. 24, 2021 (GLOBE NEWSWIRE) — Vinci Partners Investments Ltd. (NASDAQ: VINP) (“Vinci Partners”, “we”, “us”, or “our”), the controlling company of a leading alternative investment platform in Brazil, announced today the closing of R$127.7 million in capital commitments for “Vinci Infraestrutura Água e Saneamento Strategy Fundo de Investimento em Participações em Infraestrutura”, or “VIAS”, a fund managed by the Vinci Partners Infrastructure strategy. VIAS is a private equity style fund focused on investing private capital into the privatization of state-owned companies and concessions that provide water and sewage services for the Brazilian population. This fundraising marks the second closing for the VIAS strategy, which has raised so far approximately R$384 million and expects to raise up to R$1.0...

August 24, 2021 NORDIC SHIPHOLDING A/SCompany Announcement: 12/2021 Published via NASDAQ OMX on August 24, 2021Write down and revised Outlook for 2021 As stated in Company Announcement 11/2021, the merger discussions with potential merger partners have stalled.   The Company, however, is keeping its options open in its continual search for suitable merger partners. In accordance with the agreement with the lenders, management has put in place a process to sell the remaining three vessels in an orderly fashion.   Hence, an impairment loss of USD 4.5 million will be recognised in H1 2021 following the re-classification of the three remaining vessels, Nordic Agnetha, Nordic Amy and Nordic Anne, as assets held-for-sale. OutlookAssuming the remaining three vessels remain in the Hafnia Handy Pool and Hafnia LR Pool respectively until they...

MIAMI, Aug. 24, 2021 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today that it has filed a Form 6-K with the SEC disclosing the Company entered into a Research Project Agreement with The University of Melbourne o gather data and bio-markers to target Hallucinogen Persisting Perception Disorder (“HPPD”) on July 2, 2021. Investors can find the 6-K filing at https://www.sec.gov/Archives/edgar/data/0001653606/000149315221020983/form6-k.htm. About Ehave, Inc. Ehave, Inc. is a leader of digital therapeutics delivering evidence-based therapeutic interventions to patients. Our primary focus is on improving the standard care in therapeutics to prevent or treat brain disorders or diseases through the use of...

Company expects 3Q and 4Q growth to be more than 80% over same period last year and over 340% from the first half of 2021 HOUSTON, Aug. 24, 2021 (GLOBE NEWSWIRE) — C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, today announced revenue guidance for the second half of 2021 in excess of $1 million, which reflects growth of more than 80% over same period last year and over 340% from the first half of 2021. As previously announced, the company has received several large purchase orders and has started installations for many of these. Revenue growth for the second half of 2021 is expected to be generated from growth of the Company’s Patriot Glass Solutions division as well as sales from the Company’s Transportation Solutions Group, consisting primarily of C-Bond nanoShield, the Company’s patented...

Kelowna, BC, Aug. 24, 2021 (GLOBE NEWSWIRE) — Avant Brands Inc (TSX: AVNT) (OTCQX: AVTBF) (FRA: 1BUP) (“Avant”), a leading producer of handcrafted, high quality cannabis products, announces that it has been added to the Global X Cannabis ETF (NASDAQ: POTX), which is listed on the NASDAQ exchange. “Our recent efforts to expand our investor base by rebranding with concurrent dual graduations to the Toronto Stock Exchange and OTCQX have resulted in Avant gaining institutional exposure,” said Norton Singhavon, Founder and CEO of Avant Brands. “Our inclusion in the Global X Cannabis ETF will provide us with the opportunity to continue expanding our exposure to investors and institutions across North America and globally.” The Global X Cannabis ETF seeks to invest in companies across the cannabis industry. This includes companies involved...

SALT LAKE CITY, UT, Aug. 24, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Sky440, Inc. (OTC: SKYF) announced today an update on the direction and structure moving forward for Sky440. The company has updated its filing with the Nevada Secretary of State and is active, and looks to get current with OTC Markets. Sky440 is currently pursuing product development plans to launch new products during the fourth quarter of 2021 for the purpose of generating revenue into the company. The company is looking at acquisitions in the real estate, technology, and cryptocurrency vertical(s) and related technologies. We are looking to have the company structure launched in Q4 2021 in order to push the company to a solid organization and with clear direction on Sky440’s revenue generating goals. Additional information about Sky440 will be available...

SpareBank 1 SMN has today issued new senior non-preferred bond of NOK 500 million. Settlement date is September 2 2021 and maturity date November 2 2027. First call option is November 2 2026. SpareBank 1 Markets acted as sole manager. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Phase 3 Study Initiation Still Expected Fall 2021 AUSTIN, Texas, Aug. 24, 2021 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) under a Special Protocol Assessment (SPA) for both of its pivotal Phase 3 studies of oral simufilam for the treatment of patients with Alzheimer’s disease. These SPA agreements document that FDA has reviewed and agreed upon the key design features of Cassava Sciences’ Phase 3 study protocols of simufilam for the treatment of patients with Alzheimer’s disease. “I believe these SPAs mark a meaningful and encouraging milestone for Cassava Sciences,” said Remi Barbier, President & CEO. “The SPAs underscore our alignment with FDA on key scientific,...